Explore the NIH's new policy ending federal funding for fetal tissue research from elective abortions and its ethical, scientific, and political...
Vous n'êtes pas connecté
Maroc - NLM.NIH.GOV - NLM News and Events - 18/11/2024 14:57
A team of researchers from NIH’s National Library of Medicine and National Cancer Institute developed an AI algorithm that could successfully identify relevant clinical trials for which a person is eligible and provide a summary that clearly explains how that person meets the criteria for study enrollment. The tool can help make it easier for both clinicians and patients to find and connect with the right clinical trial opportunities.
Explore the NIH's new policy ending federal funding for fetal tissue research from elective abortions and its ethical, scientific, and political...
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest...
The clinical trials market is being driven by a combination of factors including increasing R&D budgets, shorter clinical timelines, and...
Competitive: Worldwide Clinical Trials - USA: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path...
SUNDAY, Jan. 25, 2026 — The National Institutes of Health (NIH) said that it will stop funding all research that uses human fetal tissue, ending...
The bU.S. National Institutes of Health (NIH)/b has announced a new policy that bends federal funding for scientific research using human fetal...
New research from a regional Australian cancer centre has assessed the practical utility of molecular tumour profiling (MTP) for patients with...
New research from a regional Australian cancer centre has assessed the practical utility of molecular tumour profiling (MTP) for patients with...
Researchers developed criteria for triaging suspected UTIs, focusing on antibiotic use and urine testing to improve outpatient care and telehealth...
Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...